Accurate, patient-specific IV insulin dosing for all patient demographics in your hospital, ages 2 and up. This application also includes the only FDA-cleared solution for IV mealtime dosing and reliable transition to SubQ insulin dosing module.
The only FDA-cleared solution for addressing the unique needs of patients aged 2 to 17 years (IV and SubQ).
The GlyCloud™ platform is backed by our commitment to the protection and security
of ePHI, providing a secure and HIPAA-compliant, multi-tenant cloud infrastructure.
The platform allows for the rapid delivery of our core applications, reduced up-front
capital expense, enhanced security and disaster recovery capability.
The SmartClick™ identity management platform provides users with one-click access
to our core applications, eliminating the need to remember additional usernames
and passwords. Patient context management allows users to bypass the login screen
and immediately see the appropriate patient chart.
GlucoMetrics consist of a powerful analytics engine and suite of reports used to measure
and monitor the success of inpatient glycemic control initiatives. The analytic engine
provides instant access to data aggregated from the hospital and/or hospital system
through reports that can be used to identify benchmark performance metrics, measure
the effectiveness of initiatives, and offer detailed reporting on relevant adverse events.
real-time results to discover meaningful patterns in a patient's glucose history. Patients
experiencing dysglycemia, anywhere in the hospital, are identified
and flagged as potential candidates for insulin therapy. In one click, caregivers can begin
treatment of these patients in Glucommander IV™ or Glucommander SubQ™.